Oral triptan therapy.
نویسنده
چکیده
Oral and Intranasal Triptan Therapy for Acute Migraine Headache The “triptans” are a family of drugs that were developed to treat acute migraine headache. Your doctor has prescribed for you 1 of the oral triptans: Imitrex (sumatriptan), Amerge (naratriptan), Zomig (zolmitriptan), Maxalt (rizatriptan), Axert (almotriptan), Frova (frovatriptan), or Relpax (eletriptan). Alternatively, he/she may have prescribed 1 of the 2 triptans marketed as nasal sprays: Imitrex nasal spray or Zomig nasal spray. Although all of the oral and intranasal triptans initially were investigated for the treatment of migraine headache of moderate to severe intensity and were superior to placebo in those pivotal trials, they appear to be more consistently effective when used to treat migraine earlier in the attack, when the headache is still mild to moderate. Ideally, the oral or intranasal triptans should be used as follows.
منابع مشابه
Post Hoc Subanalysis of Two Randomized, Controlled Phase 3 Trials Evaluating Diclofenac Potassium for Oral Solution: Impact of Migraine‐Associated Nausea and Prior Triptan Use on Efficacy
OBJECTIVE To determine whether baseline nausea or prior triptan treatment for migraine impact the effectiveness of diclofenac potassium for oral solution in treating acute migraine. BACKGROUND A great deal of variability exists in patients' response to migraine medications. Migraine-associated nausea is common and debilitating and can reduce the effectiveness of oral medications. It may cause...
متن کاملExpert Opinion Determining Triptan Preference for the Individual Patient
Prescribing a triptan for an individual patient is really conducting a triptan preference trial with an n of 1. With the availability of seven triptans, it would not be practical, however, to give the patient three samples of each oral triptan and have them take each triptan when headaches are of a similar degree of intensity (for a total of 21 trials) and then rate their preferences. This is a...
متن کاملCosts and utilization of triptan users who receive drug prophylaxis for migraine versus triptan users who do not receive drug prophylaxis.
OBJECTIVES The objectives were 2-fold: (1) to describe the utilization patterns of new users of triptan therapy and (2) to measure the direct (pharmacy and medical) costs of migraine-related health care services in moderate-to-severe migraine patients treated with drug prophylaxis compared with migraine patients who are not treated with drug prophylaxis. METHODS A retrospective administrative...
متن کاملHealth care resource utilization following initiation of a triptan: a retrospective claims analysis.
BACKGROUND 23 million Americans suffer from migraine headaches, incurring more than $1 billion in direct medical costs each year (with another $13 billion in indirect productivity losses). Triptans are the most common treatment of choice for these patients; however, adherence and persistence to triptans are poor. Partly due to poor adherence to therapy, the ability of triptans to reduce the uti...
متن کاملMeta-analysis of oral triptan therapy for migraine: number needed to treat and relative cost to achieve relief within 2 hours.
OBJECTIVE To determine the cost-effectiveness of the 5-HT1B/1D agonists, or triptans, in the acute treatment of migraine. METHODS To determine the cost-effectiveness of the triptans, a meta-analysis was conducted of the efficacy data from 27 oral triptan trials, using the endpoint of "pain-free" status within 2 hours after initial dosing as the indicator of efficacy. Efficacy data were used t...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Headache
دوره 46 6 شماره
صفحات -
تاریخ انتشار 2006